Clinical Trial Update: CEFID-I (CEra Flow Improves DVT-1) [NA]

View source ↗

Summary

The clinical trial of CEFID-I (CEra Flow) for Deep Vein Thrombosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Deep Vein Thrombosis

Drugs mentioned

• CEra Flow

Snippet

Sponsor: Ceragem Clinical Inc. | Conditions: Blood Circulation Disorder, Deep Vein Thrombosis | NA | Status: COMPLETED